Sponsor or institution
Clinical trials and research at Shanghai Longwood Biopharmaceuticals Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shanghai Longwood Biopharmaceuticals Co., Ltd. that are recruiting, in China. By phase: Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Oral LW402 for moderate-to-severe atopic dermatitis
This phase 3 study tests whether oral LW402 tablets can help adults with moderate-to-severe atopic dermatitis compared with a placebo.
-
LW231 treatment for people with chronic hepatitis B
This trial tests whether LW231, given alone or with standard antiviral NUCs, is safe and can lower hepatitis B virus measures in adults with chronic HBV.
Quick answers
How many clinical trials run by Shanghai Longwood Biopharmaceuticals Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.